Product Description: Raludotatug is a humanized immunoglobulin G1-kappa, anti-CDH6 monoclonal antibody. Raludotatug is an antineoplastic[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
CAS Number: 2610074-56-9
Molecular Weight: N/A
Compound Purity: 98.62
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: Others